Global Chronic Kidney Disease Drugs Market to Surpass US$ 17,832.5 Million by 2030, Says Coherent Market Insights (CMI)
According to Coherent Market Insights, the global chronic kidney disease drugs market is estimated to be valued at US$ 13,220.0 million in 2022 and is expected to exhibit a CAGR of 4.5% during the forecast period (2022-2030). Increasing prevalence of chronic kidney disease is expected to drive the growth of the global chronic kidney disease drugs market. For instance, according to an article published by the University of Tennessee Health… Read More